Statement of Organization, Functions, and Delegations of Authority, 24490-24491 [2011-10504]
Download as PDF
<![CDATA[
24490
Federal Register / Vol. 76, No. 84 / Monday, May 2, 2011 / Notices
Notice of Proposed New Routine
Use in OGE/GOVT–1 System of
Records.
ACTION:
The U.S. Office of
Government Ethics (OGE) proposes to
add a new Routine Use to OGE/GOVT–
1, Executive Branch Personnel Public
Financial Disclosure Reports and Other
Name-Retrieved Ethics Program
Records. This action is necessary to
comply with the requirements of the
Privacy Act to publish in the Federal
Register notice of the existence and
character of records maintained by the
agency (5 U.S.C. 552a(e)(4)). OGE last
published OGE/GOVT–1 in 68 FR 3097–
3109 (January 22, 2003), as corrected at
68 FR 24744 (May 8, 2003).
DATES: This action will be effective
without further notice on June 1, 2011
unless comments received before this
date would result in a contrary
determination.
ADDRESSES: You may submit comments
to OGE on this Privacy Act Notice by
any of the following methods:
E-mail: usoge@oge.gov (Include
reference to ‘‘Privacy Act New Routine
Use Comment’’ in the subject line of the
message).
Fax: 202–482–9237, Attention: Elaine
Newton, Privacy Officer.
Mail, Hand Delivery/Courier: Office of
Government Ethics, Suite 500, 1201
New York Avenue, NW., Washington,
DC 20005–3917, Attention: Elaine
Newton, Privacy Officer.
FOR FURTHER INFORMATION CONTACT: Ms.
Newton at the Office of Government
Ethics; telephone: 202–482–9265; TTY:
800–877–8339; FAX: 202–482–9237; Email: enewton@oge.gov.
SUPPLEMENTARY INFORMATION: In
accordance with the Privacy Act of
1974, 5 U.S.C. 552(a), this document
provides public notice that the OGE is
proposing to adopt a new Routine Use
(l.) in OGE/GOVT–1, Executive Branch
Personnel Public Financial Disclosure
Reports and Other Name-Retrieved
Ethics Program Records. This addition
will not affect any Privacy Act rights
afforded individuals who are the subject
of such records. The new Routine Use
is being proposed to provide relevant
and necessary information to Federal
Government Web sites and to any
person in support of the Ethics in
Government Act of 1978, 5 U.S.C. app.
110; the conflicts of interest criminal
statutes, 18 U.S.C. 202–209; the
Standards of Ethical Conduct for
Employees of the Executive Branch, 5
CFR part 2635; Memorandum on
Transparency and Open Government, 74
FR 4685 (Jan. 26, 2009); and in support
of this Administration’s core principles
mstockstill on DSKH9S0YB1PROD with NOTICES6
SUMMARY:
VerDate Mar<15>2010
17:48 Apr 29, 2011
Jkt 223001
of the business of government,
transparency, participation,
collaboration and innovation.
The system report, as required by 5
U.S.C. 552a(r), has been submitted to
the Committee on Homeland Security
and Governmental Affairs of the United
States Senate, the Committee on
Oversight and Government Reform of
the House of Representatives and the
Office of Management and Budget.
Dated: April 26, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Routine Use (l.)
Centers for Disease Control and
Prevention
(l.) to disclose on the OGE Web site
and to otherwise disclose to any person,
including other departments and
agencies, any written ethics agreements
filed with the Office of Government
Ethics, pursuant to 5 CFR 2634.803, by
an individual nominated by the
President to a position requiring Senate
confirmation when the position also
requires the individual to file a public
financial disclosure report.
Approved: April 25, 2011.
Robert I. Cusick,
Director, Office of Government Ethics.
[FR Doc. 2011–10628 Filed 4–29–11; 8:45 am]
BILLING CODE 6345–03–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Funding
Opportunity Announcement DD11–005,
Initial Review
Correction: This notice was published
in the Federal Register on April 11,
2011, Volume 76, Number 69, Page
19995. The time for the aforementioned
meeting has been changed to the
following:
Time: 11 a.m.–5 p.m.
Contact Person for More Information:
Brenda Colley Gilbert, Ph.D., M.P.H.,
Director, Extramural Research Program
Office, National Center for Chronic
Disease Prevention and Health
Promotion, CDC, 1600 Clifton Road,
NE., Mailstop K92, Atlanta, Georgia
30333, Telephone: (770) 488–6295.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
[FR Doc. 2011–10546 Filed 4–29–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 76 FR 15984–15985,
dated March 22, 2011) is amended to
reflect the reorganization of the National
Center on Birth Defects and
Developmental Disabilities, Office of
Noncommunicable Diseases, Injury and
Environmental Health, Centers for
Disease Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete item (7) of the functional
statement for the Office of the Director
(CUB 1), National Center on Birth
Defects and Developmental Disabilities
(CUB) and insert the following: (7)
serves as primary liaison between
NCBDDD and the CDC Office of the
Associate Director for Communications
and its associated research and practice.
Following the title and functional
statement for the Division of Human
Development and Disability (CUBC),
insert the following:
Office of the Director (CUBC1). (1)
Provides leadership and guidance on
strategic planning and implementation,
program priority setting, and policy
development, to advance the mission of
the division, NCBDDD, and CDC; (2)
develops goals, objectives, and budget;
monitors progress and allocation of
resources, and reports
accomplishments, future directions, and
resource requirements; (3) facilitates
scientific, policy and program
collaboration among divisions and
centers, and between CDC and other
federal/non-federal partners; (4)
promotes advancement of science
throughout the division, supports
program evaluation, and ensures that
research meets the highest standards in
the field; (5) provides medical expertise
E:\FR\FM\02MYN1.SGM
02MYN1
mstockstill on DSKH9S0YB1PROD with NOTICES6
Federal Register / Vol. 76, No. 84 / Monday, May 2, 2011 / Notices
and consultation to planning, projects,
policies and program activities; (6)
advises the NCBDDD Office of the
Director on matters relating to human
development and disability and
coordinates division responses to
requests for technical assistance or
information on activities supported by
the division; (7) develops and produces
communications tools and public affairs
strategies to meet the needs of division
programs and mission; and (8)
represents the division at official
professional and scientific meetings,
both within and outside of CDC.
Child Development and Disability
Branch (CUBCB). (1) Collaborates with
and provides technical assistance,
consultation, and training to local, state,
federal, and international agencies,
universities, public and private
organizations on optimal child
development, disability, and health
promotion of children with or at risk of
disabilities; (2) promotes development
of data standards and standardized
procedures for data management and
program effectiveness and costs for
systems supporting optimal child
development, and disability activities;
(3) coordinates and collaborates on
recommendations for policy
development at the federal and state
levels and with the private sector to
promote social participation and
optimal child development, including
those with or at risk for disabilities; (4)
provides scientific leadership and
technical assistance in the development,
application, improvement and
evaluation of public health activities,
systems, and interventions supporting
optimal child development, including
those with or at risk for disabilities; (5)
conducts research to expand the
knowledge base related to optimal early
development and health of children
with or at risk of disabilities, and
investigates costs and effectiveness of
intervention programs and systems; (6)
supports the development and
utilization of activities necessary for
health promotion and prevention of
secondary conditions in children of all
ages who have or are at risk for
disabilities and their families; (7)
supports and enhances public health
capacity, including surveillance and
data sharing, for promoting optimal
health and development of infants and
children with or at risk for disabilities
and their families across the lifespan; (8)
develops and disseminates information
from surveillance and epidemiologic
research, health promotion and disease
prevention strategies, and policies
related to public health aspects of
typical and atypical child development;
VerDate Mar<15>2010
17:48 Apr 29, 2011
Jkt 223001
and (9) provides leadership in health
promotion and child development for
infants and children with or at risk for
delays or disabilities and their families.
Disability and Health Branch
(CUBCC). (1) Collaborates with and
provides technical assistance,
consultation, and training to local, state,
federal, and international agencies,
universities and governmental and nongovernmental organizations on
disability and health related issues; (2)
collaborates with local, state, federal,
and international agencies, and
appropriate governmental and nongovernmental organizations to develop,
review, and implement policies that
advance the health of people with
disabilities across the lifespan; (3)
provides scientific leadership in the
development, application, extension,
and improvement of health surveillance
and tracking systems related to
disability and health; (4) conducts and
supports both qualitative and
quantitative research to expand the
knowledge base related to disability and
health across the lifespan; (5) supports
the development and utilization of
secondary condition prevention
activities for people with specific or
categorical disabilities; (6) supports and
coordinates state public health capacity
for promoting the health of people with
disabilities; (7) disseminates
information from surveillance and
health services research,
epidemiological research, health
promotion and disease prevention
strategies, and policies related to
disability and health; (8) establishes
collaborative partnerships with public
and private organizations of national
and international stature to promote the
health of people with disabilities; (9)
collaborates with funded
nongovernmental agencies to
disseminate best practices, identify
areas of need, facilitate development
and distribution of educational
materials, and provide informational
resources to states and affected
populations and their caregivers; and
(10) provides leadership in health
promotion and disease prevention
across the lifespan for individuals with
disabilities.
Dated: April 10, 2011.
James D. Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–10504 Filed 4–29–11; 8:45 am]
BILLING CODE 4160–18–M
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
24491
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 76 FR 15984–15985,
dated March 22, 2011) is amended to
reflect the reorganization of the National
Center for Immunization and
Respiratory Diseases, Office of
Infectious Diseases, Centers for Disease
Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows: Delete in its entirety the
function statements for the National
Center for Immunization and
Respiratory Disease (CVG) and the
Office of the Director (CVG1) and insert
the following:
National Center for Immunization
and Respiratory Diseases (CVG). The
National Center for Immunization and
Respiratory Diseases (NCIRD) prevents
disease, disability, and death through
immunization and by control of
respiratory and related diseases. In
carrying out its mission, NCIRD: (1)
Provides leadership, expertise, and
service in laboratory and
epidemiological sciences, and in
immunization program delivery; (2)
conducts applied research on disease
prevention and control; (3) translates
research findings into public health
policies and practices; (4) provides
diagnostic and reference laboratory
services to relevant partners; (5)
conducts surveillance and research to
determine disease distribution,
determinants, and burden nationally
and internationally; (6) responds to
disease outbreaks domestically and
abroad; (7) ensures that public health
decisions are made objectively and
based upon the highest quality of
scientific data; (8) provides technical
expertise, education, and training to
domestic and international partners; (9)
provides leadership to internal and
external partners for establishing and
maintaining immunization, and other
prevention and control programs; (10)
develops, implements, and evaluates
domestic and international public
health policies; (11) communicates
information to increase awareness,
E:\FR\FM\02MYN1.SGM
02MYN1
]]>Agencies
[Federal Register Volume 76, Number 84 (Monday, May 2, 2011)]
[Notices]
[Pages 24490-24491]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-10504]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 76 FR 15984-15985, dated March 22, 2011) is
amended to reflect the reorganization of the National Center on Birth
Defects and Developmental Disabilities, Office of Noncommunicable
Diseases, Injury and Environmental Health, Centers for Disease Control
and Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete item (7) of the functional statement for the Office of the
Director (CUB 1), National Center on Birth Defects and Developmental
Disabilities (CUB) and insert the following: (7) serves as primary
liaison between NCBDDD and the CDC Office of the Associate Director for
Communications and its associated research and practice.
Following the title and functional statement for the Division of
Human Development and Disability (CUBC), insert the following:
Office of the Director (CUBC1). (1) Provides leadership and
guidance on strategic planning and implementation, program priority
setting, and policy development, to advance the mission of the
division, NCBDDD, and CDC; (2) develops goals, objectives, and budget;
monitors progress and allocation of resources, and reports
accomplishments, future directions, and resource requirements; (3)
facilitates scientific, policy and program collaboration among
divisions and centers, and between CDC and other federal/non-federal
partners; (4) promotes advancement of science throughout the division,
supports program evaluation, and ensures that research meets the
highest standards in the field; (5) provides medical expertise
[[Page 24491]]
and consultation to planning, projects, policies and program
activities; (6) advises the NCBDDD Office of the Director on matters
relating to human development and disability and coordinates division
responses to requests for technical assistance or information on
activities supported by the division; (7) develops and produces
communications tools and public affairs strategies to meet the needs of
division programs and mission; and (8) represents the division at
official professional and scientific meetings, both within and outside
of CDC.
Child Development and Disability Branch (CUBCB). (1) Collaborates
with and provides technical assistance, consultation, and training to
local, state, federal, and international agencies, universities, public
and private organizations on optimal child development, disability, and
health promotion of children with or at risk of disabilities; (2)
promotes development of data standards and standardized procedures for
data management and program effectiveness and costs for systems
supporting optimal child development, and disability activities; (3)
coordinates and collaborates on recommendations for policy development
at the federal and state levels and with the private sector to promote
social participation and optimal child development, including those
with or at risk for disabilities; (4) provides scientific leadership
and technical assistance in the development, application, improvement
and evaluation of public health activities, systems, and interventions
supporting optimal child development, including those with or at risk
for disabilities; (5) conducts research to expand the knowledge base
related to optimal early development and health of children with or at
risk of disabilities, and investigates costs and effectiveness of
intervention programs and systems; (6) supports the development and
utilization of activities necessary for health promotion and prevention
of secondary conditions in children of all ages who have or are at risk
for disabilities and their families; (7) supports and enhances public
health capacity, including surveillance and data sharing, for promoting
optimal health and development of infants and children with or at risk
for disabilities and their families across the lifespan; (8) develops
and disseminates information from surveillance and epidemiologic
research, health promotion and disease prevention strategies, and
policies related to public health aspects of typical and atypical child
development; and (9) provides leadership in health promotion and child
development for infants and children with or at risk for delays or
disabilities and their families.
Disability and Health Branch (CUBCC). (1) Collaborates with and
provides technical assistance, consultation, and training to local,
state, federal, and international agencies, universities and
governmental and non-governmental organizations on disability and
health related issues; (2) collaborates with local, state, federal, and
international agencies, and appropriate governmental and non-
governmental organizations to develop, review, and implement policies
that advance the health of people with disabilities across the
lifespan; (3) provides scientific leadership in the development,
application, extension, and improvement of health surveillance and
tracking systems related to disability and health; (4) conducts and
supports both qualitative and quantitative research to expand the
knowledge base related to disability and health across the lifespan;
(5) supports the development and utilization of secondary condition
prevention activities for people with specific or categorical
disabilities; (6) supports and coordinates state public health capacity
for promoting the health of people with disabilities; (7) disseminates
information from surveillance and health services research,
epidemiological research, health promotion and disease prevention
strategies, and policies related to disability and health; (8)
establishes collaborative partnerships with public and private
organizations of national and international stature to promote the
health of people with disabilities; (9) collaborates with funded
nongovernmental agencies to disseminate best practices, identify areas
of need, facilitate development and distribution of educational
materials, and provide informational resources to states and affected
populations and their caregivers; and (10) provides leadership in
health promotion and disease prevention across the lifespan for
individuals with disabilities.
Dated: April 10, 2011.
James D. Seligman,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2011-10504 Filed 4-29-11; 8:45 am]
BILLING CODE 4160-18-M
